Recently, using a schistosome protein microarray, a predicted S. japonicum acetylcholinesterase precursor (AY810792) was significantly targeted by protective IgG1 immune responses in S. haematobium-exposed individuals that had acquired drug-induced resistance to schistosomiasis after praziquantel treatment [12]. Here, ACHE is linked to schistosomiasis.